MARKET

NEO

NEO

Neogenomics Inc
NASDAQ
15.50
-0.34
-2.15%
Pre Market: 15.00 -0.5 -3.23% 04:20 07/18 EDT
OPEN
15.65
PREV CLOSE
15.84
HIGH
15.98
LOW
15.45
VOLUME
10
TURNOVER
0
52 WEEK HIGH
21.22
52 WEEK LOW
11.03
MARKET CAP
1.98B
P/E (TTM)
-23.1412
1D
5D
1M
3M
1Y
5Y
1D
NeoGenomics’s Growth and Resilience Affirm Buy Rating: Analyst Puneet Souda’s Perspective
TipRanks · 2d ago
Weekly Report: what happened at NEO last week (0708-0712)?
Weekly Report · 3d ago
Injunction again NeoGenomics over RaDaR assay affirmed by appeals court
Injunction again NeoGenomics over RaDaR assay affirmed by appeals court. A federal court in North Carolina has issued a preliminary injunction barring the company from manufacturing and selling its cancer test. The ruling sent NeoGenomic shares plunging 18% on Dec. 28.
Seeking Alpha · 5d ago
Press Release: NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024
Dow Jones · 07/09 11:07
Weekly Report: what happened at NEO last week (0701-0705)?
Weekly Report · 07/08 11:05
Weekly Report: what happened at NEO last week (0624-0628)?
Weekly Report · 07/01 11:06
Weekly Report: what happened at NEO last week (0617-0621)?
Weekly Report · 06/24 11:13
Weekly Report: what happened at NEO last week (0610-0614)?
Weekly Report · 06/17 11:05
More
About NEO
NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.

Webull offers NeoGenomics, Inc. stock information, including NASDAQ: NEO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NEO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NEO stock methods without spending real money on the virtual paper trading platform.